320 related articles for article (PubMed ID: 26307668)
1. Suppression of EZH2 Prevents the Shift of Osteoporotic MSC Fate to Adipocyte and Enhances Bone Formation During Osteoporosis.
Jing H; Liao L; An Y; Su X; Liu S; Shuai Y; Zhang X; Jin Y
Mol Ther; 2016 Feb; 24(2):217-229. PubMed ID: 26307668
[TBL] [Abstract][Full Text] [Related]
2. EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification.
Hemming S; Cakouros D; Isenmann S; Cooper L; Menicanin D; Zannettino A; Gronthos S
Stem Cells; 2014 Mar; 32(3):802-15. PubMed ID: 24123378
[TBL] [Abstract][Full Text] [Related]
3. H3K9me-enhanced DNA hypermethylation of the p16INK4a gene: an epigenetic signature for spontaneous transformation of rat mesenchymal stem cells.
Zheng Y; He L; Wan Y; Song J
Stem Cells Dev; 2013 Jan; 22(2):256-67. PubMed ID: 22873822
[TBL] [Abstract][Full Text] [Related]
4. Identification of Novel EZH2 Targets Regulating Osteogenic Differentiation in Mesenchymal Stem Cells.
Hemming S; Cakouros D; Vandyke K; Davis MJ; Zannettino AC; Gronthos S
Stem Cells Dev; 2016 Jun; 25(12):909-21. PubMed ID: 27168161
[TBL] [Abstract][Full Text] [Related]
5. Enhancer of Zeste Homolog 2 and Histone Deacetylase 9c Regulate Age-Dependent Mesenchymal Stem Cell Differentiation into Osteoblasts and Adipocytes.
Chen YH; Chung CC; Liu YC; Yeh SP; Hsu JL; Hung MC; Su HL; Li LY
Stem Cells; 2016 Aug; 34(8):2183-93. PubMed ID: 27250566
[TBL] [Abstract][Full Text] [Related]
6. DZNep promotes mouse bone defect healing via enhancing both osteogenesis and osteoclastogenesis.
Cao X; He W; Rong K; Xu S; Chen Z; Liang Y; Han S; Zhou Y; Yang X; Ma H; Qin A; Zhao J
Stem Cell Res Ther; 2021 Dec; 12(1):605. PubMed ID: 34930462
[TBL] [Abstract][Full Text] [Related]
7. KDM5A controls bone morphogenic protein 2-induced osteogenic differentiation of bone mesenchymal stem cells during osteoporosis.
Wang C; Wang J; Li J; Hu G; Shan S; Li Q; Zhang X
Cell Death Dis; 2016 Aug; 7(8):e2335. PubMed ID: 27512956
[TBL] [Abstract][Full Text] [Related]
8. Enhancer of Zeste Homolog 2 Inhibition Stimulates Bone Formation and Mitigates Bone Loss Caused by Ovariectomy in Skeletally Mature Mice.
Dudakovic A; Camilleri ET; Riester SM; Paradise CR; Gluscevic M; O'Toole TM; Thaler R; Evans JM; Yan H; Subramaniam M; Hawse JR; Stein GS; Montecino MA; McGee-Lawrence ME; Westendorf JJ; van Wijnen AJ
J Biol Chem; 2016 Nov; 291(47):24594-24606. PubMed ID: 27758858
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2.
Dudakovic A; Camilleri ET; Xu F; Riester SM; McGee-Lawrence ME; Bradley EW; Paradise CR; Lewallen EA; Thaler R; Deyle DR; Larson AN; Lewallen DG; Dietz AB; Stein GS; Montecino MA; Westendorf JJ; van Wijnen AJ
J Biol Chem; 2015 Nov; 290(46):27604-17. PubMed ID: 26424790
[TBL] [Abstract][Full Text] [Related]
10. β-Catenin Preserves the Stem State of Murine Bone Marrow Stromal Cells Through Activation of EZH2.
Sen B; Paradise CR; Xie Z; Sankaran J; Uzer G; Styner M; Meyer M; Dudakovic A; van Wijnen AJ; Rubin J
J Bone Miner Res; 2020 Jun; 35(6):1149-1162. PubMed ID: 32022326
[TBL] [Abstract][Full Text] [Related]
11. EZH2 suppresses hepatocellular differentiation of mouse bone marrow mesenchymal stem cells.
Lu T; Sun H; Lv J; Yang MF; Zhang F; Qian Y; Dong XJ
Genet Mol Res; 2014 Mar; 13(1):2231-9. PubMed ID: 24737471
[TBL] [Abstract][Full Text] [Related]
12. The GDF11-FTO-PPARγ axis controls the shift of osteoporotic MSC fate to adipocyte and inhibits bone formation during osteoporosis.
Shen GS; Zhou HB; Zhang H; Chen B; Liu ZP; Yuan Y; Zhou XZ; Xu YJ
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3644-3654. PubMed ID: 30279140
[TBL] [Abstract][Full Text] [Related]
13. p38α MAPK Regulates Lineage Commitment and OPG Synthesis of Bone Marrow Stromal Cells to Prevent Bone Loss under Physiological and Pathological Conditions.
Cong Q; Jia H; Biswas S; Li P; Qiu S; Deng Q; Guo X; Ma G; Ling Chau JF; Wang Y; Zhang ZL; Jiang X; Liu H; Li B
Stem Cell Reports; 2016 Apr; 6(4):566-578. PubMed ID: 26947973
[TBL] [Abstract][Full Text] [Related]
14. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
15. 1,25-Dihydroxyvitamin D protects against age-related osteoporosis by a novel VDR-Ezh2-p16 signal axis.
Yang R; Chen J; Zhang J; Qin R; Wang R; Qiu Y; Mao Z; Goltzman D; Miao D
Aging Cell; 2020 Feb; 19(2):e13095. PubMed ID: 31880094
[TBL] [Abstract][Full Text] [Related]
16. Histone H3K27 methyltransferase Ezh2 represses Wnt genes to facilitate adipogenesis.
Wang L; Jin Q; Lee JE; Su IH; Ge K
Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7317-22. PubMed ID: 20368440
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA HoxA-AS3 interacts with EZH2 to regulate lineage commitment of mesenchymal stem cells.
Zhu XX; Yan YW; Chen D; Ai CZ; Lu X; Xu SS; Jiang S; Zhong GS; Chen DB; Jiang YZ
Oncotarget; 2016 Sep; 7(39):63561-63570. PubMed ID: 27566578
[TBL] [Abstract][Full Text] [Related]
18. MiR-101 Targets the EZH2/Wnt/β-Catenin the Pathway to Promote the Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells.
Wang H; Meng Y; Cui Q; Qin F; Yang H; Chen Y; Cheng Y; Shi J; Guo Y
Sci Rep; 2016 Nov; 6():36988. PubMed ID: 27845386
[TBL] [Abstract][Full Text] [Related]
19. The histone methyltransferase EZH2 promotes mammary stem and luminal progenitor cell expansion, metastasis and inhibits estrogen receptor-positive cellular differentiation in a model of basal breast cancer.
Wu J; Crowe DL
Oncol Rep; 2015 Jul; 34(1):455-60. PubMed ID: 25998860
[TBL] [Abstract][Full Text] [Related]
20. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
